Gallic Acid-g-Chitosan Modulates Inflammatory Responses in LPS-Stimulated RAW264.7 Cells Via NF-κB, AP-1, and MAPK Pathways

Gallic Acid-g-Chitosan Modulates Inflammatory Responses in LPS-Stimulated RAW264.7 Cells Via NF-κB, AP-1, and MAPK Pathways
复制标题

DOI:
10.1007/s10753-015-0258-2
复制
发表时间:
2016-02-01
期刊:
影响因子:
5.1
通讯作者:
Je, Jae-Young
Je, Jae-Young
中科院分区:
医学2区
文献类型:
--
作者:
Ahn, Chang-Bum;Jung, Won-Kyo;Je, Jae-Young

文献摘要

被引文献

相似文献

壳聚糖是一种天然存在的多糖,其具有抗氧化、抗微生物和抗癌等活性。壳聚糖接枝酚类化合物是提高壳聚糖生物活性的有效途径。我们研究了没食子酸接枝壳聚糖(GAC)在脂多糖(LPS)刺激的RAW 264.7巨噬细胞中的抗炎作用。GAC通过抑制LPS刺激的RAW 264.7巨噬细胞诱导型一氧化氮合酶(iNOS)和环氧合酶-2(考克斯-2)的表达,抑制NO和前列腺素E2(PGE(2))的产生。GAC还抑制促炎细胞因子如肿瘤坏死因子α(TNF-α)、白细胞介素-1 β(IL-1 β)和白细胞介素-6(IL-6)的产生和mRNA表达。GAC通过抑制核因子-κ B抑制剂I κ B的磷酸化和降解而灭活核因子-κ B(NF-κ B)。此外,GAC通过细胞外信号调节激酶(ERK 1/2)、p38 MAPK和c-Jun N-末端激酶/应激活化蛋白激酶(JNK)等促分裂原活化蛋白激酶(MAPK)的磷酸化抑制活化蛋白-1(AP-1)的活化。这些结果表明,GAC具有潜在的抗炎作用,通过下调转录因子(NF-κ B和AP-1)通过MAPK信号通路。
Chitosan is a naturally occurring polysaccharide, which has exhibited antioxidant, antimicrobial, and anti-cancer activities among others. Modification of chitosan by grafting phenolic compounds is a good strategy for improvement of bioactivities of chitosan. We investigated the anti-inflammatory action of gallic acid-grafted-chitosan (GAC) in lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages. GAC inhibited the production of nitric oxide (NO) and prostaglandin E2 (PGE(2)) by inhibiting inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression in LPS-stimulated RAW264.7 macrophages. GAC also suppressed the production and mRNA expression of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), and interleukin-6 (IL-6). GAC inactivated nuclear factor-kappa B (NF-kappa B) via inhibiting the phosphorylation and degradation of the NF-kappa B inhibitor, I kappa B. In addition, GAC suppresses the activation of activator protein-1 (AP-1) through the phosphorylation of mitogen-activated protein kinase (MAPK) such as extracellular signal-regulated kinase (ERK1/2), p38 MAPK, and c-Jun N-terminal kinase/stress-activated protein kinase (JNK). These results suggest that GAC has the potential anti-inflammatory action by downregulating transcriptional factors (NF-kappa B and AP-1) through MAPK signaling pathways.